Elon Musk has denied reports that his brain implant startup Neuralink killed monkeys during research experiments, claiming instead that tests were only done on “terminal” primates. Neuralink admitted to euthanizing eight animals during trials of its brain-computer interface technology last year, however denied accusations from the Physicians Committee for Responsible Medicine (PCRM) that it subjected monkeys to “extreme suffering”. The animal rights group accused Neuralink of “inadequate animal care” at the company’s lab at the University of California’s Davis Primate Centre, alleging that nine violations of the Animal Welfare Act were committed. Neuralink defended its animal testing record in a blog post last year, claiming that it is “absolutely committed to working with animals in the most humane and ethical way possible”. The firm also noted that “all novel medical devices and treatments” must be tested on animals before they can be trialled on humans. “The use of every animal was extensively planned and considered to balance scientific discovery with the ethical use of animals,” the blog post stated. Neuralink CEO Elon Musk has now added more details about the startup’s animal testing practices, after the issue was brought up by one of his followers on X, formerly known as Twitter. “No monkey has died as a result of a Neuralink implant,” Mr Elon Musk posted to X. “First our early implants, to minimise risk to healthy monkeys, we chose terminal monkeys (close to death already).” Mr Musk founded Neuralink in 2016 with the ultimate aim of merging artificial intelligence with the human brain. An implanted chip could improve hearing and vision, while also delivering “enhanced abilities” like greater reasoning and anxiety relief, according to the tech billionaire. Early applications of the technology will be for treating brain disorders and neurological conditions, though the company is yet to set a date for when its chips will be ready to use. In May, Neuralink revealed that it had received approval from the US Food and Drug Administration (FDA) to begin testing its technology on humans. Neuralink said that FDA approval “represents an important first step that will one day allow our technology to help many people”. Read More 10 ways AI will change the world – from curing cancer to wiping out humanity SpaceX launch of Starship rocket on hold amid ‘mishap investigation’ Famed tech journalist deletes X account with epic rant at Elon Musk First photo emerges of Elon Musk and his baby twins with Neuralink director

TEMPE, Ariz.--(BUSINESS WIRE)--May 12, 2023--

By Hannah Lang and Chris Prentice The U.S. Securities and Exchange Commission (SEC) on Tuesday asked a federal

DETROIT--(BUSINESS WIRE)--Jun 7, 2023--

Samsung Electronics and SK Hynix will be allowed to supply US chip equipment to their China factories indefinitely without separate US approvals, South Korea's presidential office and the companies said on Monday.

Notes on the media in St Vincent and the Grenadines, links to the broadcasters and newspapers

'Alan Wake 2' is arriving on October 27.

(Reuters) -Bumble forecast fourth-quarter revenue below Wall Street estimates on Tuesday, in a sign that sticky inflation and growing competition

Amid fading fame, Fousey's call to Adin Ross exposed explicit details, leaving Adin shocked about Fousey's ties to his sister Naomi Ross

By Sam Nussey TOKYO (Reuters) -Nintendo on Tuesday raised its operating profit forecast for the financial year ending March by

COP28 Daily Reports: Sign up for the Green Daily newsletter for comprehensive coverage of the climate summit right

Nationwide, students have been absent at record rates since schools reopened after COVID-forced closures